• Skip to main content
  • Skip to footer

PeDRA

Pediatric Dermatology Research Alliance

  • Pay 2021 Membership Dues
  • Our Membership
  • Login
MENUMENU
  • Contact Us
  • For Patients & Families
        • Patient Support
        • Patient Education
        • Find a Pediatric Dermatologist (from SPD)
        • Clinical Trials
        • Patient Advisory Committee
        • Learn more about PeDRA’s efforts to build capacity for patient engagement in pediatric dermatology research.

           

  • Education and Events
        • Virtual Education
        • PeDRA Podcasts
        • Mentorship Program
        • Early Career Support
        • 2021 PeDRA Annual Conference
        • Past PeDRA Conferences
        • Upcoming Events
        • Education and Events Archive
        • Save the Date!

          The 2021 PeDRA Annual Conference will take place October 14-16, 2021 in Bethesda, MD.

           

  • Research
        • Grants & Awards
        • Studies
        • Focused Study Groups
        • Publications
        • Clinical Trials
        • Spring Funding Opportunities

          2021 Research Fellowships
          due April 1
          2021 Childhood Eczema Challenge Grant
          due May 4

  • About
        • Mission & Vision
        • Leadership & Staff
        • Annual Reports
        • News Archive
        • Our Supporters
        • Our Membership
        • Our Committees
        • Getting to Know You
        • PeDRA is an independent 501(c)(3) nonprofit organization driven by the mission to create, inspire, and sustain research to prevent, treat, and cure childhood skin disease.

  • Member Login

Fatal Pediatric Melanoma Retrospective Study

November 10, 2019 By Mike Siegel

Principal Investigator:

Elena Hawryluk, MD, PhD
Massachusetts General Hospital

Overview:

Pediatric dermatologists have a strong interest in better understanding pediatric nevi and characterizing melanoma; the diagnostic challenge of pediatric melanomas can delay diagnosis, lead to deeper and more advanced pediatric melanomas, and potentially result in worse outcomes. A coordinated effort among pediatric dermatologists to better understand and collectively describe the clinical features with which patients present to our specialty will allow us to educate and work constructively with colleagues in pediatrics, oncology, pediatric surgery, and adult dermatology, who manage melanoma more frequently. This retrospective study will allow us to describe clinical and histopathologic data associated with a fatal outcome, and ultimately promises to inform clinicians’ management and counseling strategies for melanoma patients and their families.

Status:

This study was funded as a 2017 PeDRA Pilot Grant. One publication in print – Bartenstein, et al., 2018; (see publications page). Additional sites have been added to gather more data and analysis is underway for additional publications.

This project received a 2019 PeDRA Study Support Grant to fund a biostatistician at Boston Chidren’s Hostpial to perform analysis on the additional data gathered, and provide support as abstracts and manuscripts are prepared.

Filed Under: Active Studies, Skin Tumors and Reactions to Cancer Therapies

Footer

  • Our Membership
  • For Patients
  • For Researchers
  • Facebook
  • Instagram
  • LinkedIn
  • Twitter
Sign up to receive emails from PeDRA
Join PeDRA
Donate

Copyright © 2021 · Pediatric Dermatology Research Alliance (PeDRA) · All Rights Reserved. · Privacy Policy